Search Results
Results found for "Norton Cheng"
- Radioligands vs. Fluorescent Ligands: Binding Assays
with a higher specific activity, but a shorter half-life (60 days), which complicates storage, besides changing
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
In all cases, the receptor interaction changes downstream signalling and the responses to receptor agonists
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
Structural analysis of SMO domains shows significant changes in the CRD and ICD, during the course of
- How Schild Analysis Protects Your Conclusions in GPCR Research
Anyone who joins before the change is fully grandfathered — your rate stays locked, and your whole team
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
Target Engagement—Don’t Chase It with Irreversible Drugs When binding outlives exposure, everything changes
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
. 🎧 Go behind the scenes with Revvity —from the chemistry to the critical moments that changed everything
- Fluorescence Polarization in GPCR Research
Adapted from: Zhang Y, Tang H, Chen W, Zhang J. is most effective at studying interactions between large proteins and small ligands thanks to this change
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Every time a problem arises, we trace it back to its root cause, implementing changes that prevent its
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Here, we investigate the conformational changes induced by the binding of a nanobody (Nb80) on the active-like
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Crucially, altering one does not inherently change the others—a principle often overlooked in early discovery
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
This paper thoroughly investigated the role of single amino acid changes to clarify the molecular mechanisms
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
Seeing that probe expose receptor distribution across an entire native islet changed what they believed
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
clarity—so you can pick better targets, stress-test hypotheses earlier, and focus on experiments that change
- The Five Traps of Ignoring Kinetics
That’s where Terry’s Corner changes the game.
- 📰 GPCR Weekly News, April 1 to 7, 2024
Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook Sosei Heptares officially changed
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Guo, W., et al., Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface
- How Collaboration Drives GPCR Discoveries
That changed when JB’s team walked in with a different lens.
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
And that difference changes everything. 👉 Scientific thinking values thoroughness, error reduction,
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
Anyone who joins Premium before these changes go live will be grandfathered at their current rate , as
- 📰 GPCR Weekly News, March 4 to 10, 2024
from March 4th to 10th, 2024 GPCR Activation and Signaling Glu1022.53-Mediated Early Conformational Changes
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Why micro-domains change what “global” signaling can and can’t explain.
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
This makes it an ideal candidate for GPCR research, where accuracy in detecting subtle signaling changes
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
GPCRs has well‑known limitations—fixation artifacts, epitope masking, low expression, conformation changes
- How to Avoid the Most Common Gaps in Your Biotech Pitch
What Changes When Your Pitch Works When your biotech pitch lands, the difference is immediate and powerful
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
announced the winners of its Transforming Cancer Therapeutics grant, which focuses on developing life-changing
- 📰 GPCR Weekly News, September 18 to 24, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, September 11 to 17, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, March 6 to 12, 2023
de l'Innovation Technologique (Technological Innovation Award) Sosei Heptares Receives Approval for Change
- 📰 GPCR Weekly News, August 28 to September 3, 2023
Drug Targets: Allosteric Function and Biased Signaling" at the DOT NEW October 3, 2023 | FREE Seminar: Changing



















